Celecoxib Completed Phase 4 Trials for Ankylosing Spondylitis (AS) / Inflammatory Reaction Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01934933Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
NCT02528201A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis